The immunoregulatory effects of transforming growth factor beta (TGF-beta) and recombinant murine tumor necrosis factor alpha (rMuTNF-alpha) on CTL generation and activity were examined. The results demonstrate that TGF-beta, in a dose-dependent manner, inhibited CTL generation but not CTL activity. The inhibitory effects were detected only when TGF-beta was added within the first 48 h of the MLC. Little activity was seen when it was added thereafter, including the addition of TGF-beta to the cytotoxicity assay. The production of TNF-alpha, which occurs during early phases of the MLC and which is inhibited in the presence of TGF-beta, appears to have an important regulatory role, as altering the levels of TNF-alpha in an MLC can significantly influence CTL development. The inhibitory effects of TGF-beta on the MLC can be significantly reversed by the addition of rMuTNF-alpha to the cultures. These results demonstrate that TGF-beta can inhibit MLC and subsequent CTL generation at early stages of the reaction, and such inhibition may involve the suppression of TNF-alpha production.
Article|
October 01 1987
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
G E Ranges,
G E Ranges
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
Search for other works by this author on:
I S Figari,
I S Figari
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
Search for other works by this author on:
T Espevik,
T Espevik
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
Search for other works by this author on:
M A Palladino, Jr
M A Palladino, Jr
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
Search for other works by this author on:
G E Ranges
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
I S Figari
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
T Espevik
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
M A Palladino, Jr
Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
Online Issn: 1540-9538
Print Issn: 0022-1007
J Exp Med (1987) 166 (4): 991–998.
Citation
G E Ranges, I S Figari, T Espevik, M A Palladino; Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.. J Exp Med 1 October 1987; 166 (4): 991–998. doi: https://doi.org/10.1084/jem.166.4.991
Download citation file: